Cargando…
Patients’ Preferences for Information About the Benefits and Risks of Second-Line Palliative Chemotherapy and Their Oncologist’s Awareness of These Preferences
Communication about palliative treatment options requires a balance between providing patients with sufficient information and not providing unwanted information. Surveys have indicated that many patients with advanced cancer express a wish to receive detailed information. In this prospective multic...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4988994/ https://www.ncbi.nlm.nih.gov/pubmed/25985960 http://dx.doi.org/10.1007/s13187-015-0845-9 |
_version_ | 1782448494331559936 |
---|---|
author | Oostendorp, Linda J. M. Ottevanger, Petronella B. van de Wouw, Agnes J. Honkoop, Aafke H. Los, Maartje van der Graaf, Winette T. A. Stalmeier, Peep F. M. |
author_facet | Oostendorp, Linda J. M. Ottevanger, Petronella B. van de Wouw, Agnes J. Honkoop, Aafke H. Los, Maartje van der Graaf, Winette T. A. Stalmeier, Peep F. M. |
author_sort | Oostendorp, Linda J. M. |
collection | PubMed |
description | Communication about palliative treatment options requires a balance between providing patients with sufficient information and not providing unwanted information. Surveys have indicated that many patients with advanced cancer express a wish to receive detailed information. In this prospective multicenter study, the information desire of patients with advanced breast or colorectal cancer was further investigated by offering treatment-related information to patients using a decision aid (DA). In addition, this study explored oncologists’ awareness of their patients’ information desire. Seventy-seven patients with advanced breast or colorectal cancer facing the decision whether to start second-line palliative chemotherapy were offered a DA by a nurse. This DA contained information on adverse events, tumor response, and survival. The nurse asked the patient whether each information item was desired. Ninety-five percent of patients chose to receive information on adverse events, 91 % chose to receive information on tumor response, and 74 % chose to receive information on survival. Oncologists’ judgment of patients’ information desire was 100, 97, and 81 %, respectively. For all three information items together, oncologists correctly judged the information desire of 62 % of patients. This study confirms that many patients with advanced cancer wish to receive detailed information on the benefits and risks of palliative treatment options when the information is actually available. Oncologists were adequately aware of this high information desire, but had some difficulty judging the information desire of individual patients. A stepped approach to giving information (“preview, ask, tell, ask”) may help to better meet patients’ information needs. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s13187-015-0845-9) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4988994 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-49889942016-09-01 Patients’ Preferences for Information About the Benefits and Risks of Second-Line Palliative Chemotherapy and Their Oncologist’s Awareness of These Preferences Oostendorp, Linda J. M. Ottevanger, Petronella B. van de Wouw, Agnes J. Honkoop, Aafke H. Los, Maartje van der Graaf, Winette T. A. Stalmeier, Peep F. M. J Cancer Educ Article Communication about palliative treatment options requires a balance between providing patients with sufficient information and not providing unwanted information. Surveys have indicated that many patients with advanced cancer express a wish to receive detailed information. In this prospective multicenter study, the information desire of patients with advanced breast or colorectal cancer was further investigated by offering treatment-related information to patients using a decision aid (DA). In addition, this study explored oncologists’ awareness of their patients’ information desire. Seventy-seven patients with advanced breast or colorectal cancer facing the decision whether to start second-line palliative chemotherapy were offered a DA by a nurse. This DA contained information on adverse events, tumor response, and survival. The nurse asked the patient whether each information item was desired. Ninety-five percent of patients chose to receive information on adverse events, 91 % chose to receive information on tumor response, and 74 % chose to receive information on survival. Oncologists’ judgment of patients’ information desire was 100, 97, and 81 %, respectively. For all three information items together, oncologists correctly judged the information desire of 62 % of patients. This study confirms that many patients with advanced cancer wish to receive detailed information on the benefits and risks of palliative treatment options when the information is actually available. Oncologists were adequately aware of this high information desire, but had some difficulty judging the information desire of individual patients. A stepped approach to giving information (“preview, ask, tell, ask”) may help to better meet patients’ information needs. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s13187-015-0845-9) contains supplementary material, which is available to authorized users. Springer US 2015-05-20 2016 /pmc/articles/PMC4988994/ /pubmed/25985960 http://dx.doi.org/10.1007/s13187-015-0845-9 Text en © The Author(s) 2015 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Article Oostendorp, Linda J. M. Ottevanger, Petronella B. van de Wouw, Agnes J. Honkoop, Aafke H. Los, Maartje van der Graaf, Winette T. A. Stalmeier, Peep F. M. Patients’ Preferences for Information About the Benefits and Risks of Second-Line Palliative Chemotherapy and Their Oncologist’s Awareness of These Preferences |
title | Patients’ Preferences for Information About the Benefits and Risks of Second-Line Palliative Chemotherapy and Their Oncologist’s Awareness of These Preferences |
title_full | Patients’ Preferences for Information About the Benefits and Risks of Second-Line Palliative Chemotherapy and Their Oncologist’s Awareness of These Preferences |
title_fullStr | Patients’ Preferences for Information About the Benefits and Risks of Second-Line Palliative Chemotherapy and Their Oncologist’s Awareness of These Preferences |
title_full_unstemmed | Patients’ Preferences for Information About the Benefits and Risks of Second-Line Palliative Chemotherapy and Their Oncologist’s Awareness of These Preferences |
title_short | Patients’ Preferences for Information About the Benefits and Risks of Second-Line Palliative Chemotherapy and Their Oncologist’s Awareness of These Preferences |
title_sort | patients’ preferences for information about the benefits and risks of second-line palliative chemotherapy and their oncologist’s awareness of these preferences |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4988994/ https://www.ncbi.nlm.nih.gov/pubmed/25985960 http://dx.doi.org/10.1007/s13187-015-0845-9 |
work_keys_str_mv | AT oostendorplindajm patientspreferencesforinformationaboutthebenefitsandrisksofsecondlinepalliativechemotherapyandtheironcologistsawarenessofthesepreferences AT ottevangerpetronellab patientspreferencesforinformationaboutthebenefitsandrisksofsecondlinepalliativechemotherapyandtheironcologistsawarenessofthesepreferences AT vandewouwagnesj patientspreferencesforinformationaboutthebenefitsandrisksofsecondlinepalliativechemotherapyandtheironcologistsawarenessofthesepreferences AT honkoopaafkeh patientspreferencesforinformationaboutthebenefitsandrisksofsecondlinepalliativechemotherapyandtheironcologistsawarenessofthesepreferences AT losmaartje patientspreferencesforinformationaboutthebenefitsandrisksofsecondlinepalliativechemotherapyandtheironcologistsawarenessofthesepreferences AT vandergraafwinetteta patientspreferencesforinformationaboutthebenefitsandrisksofsecondlinepalliativechemotherapyandtheironcologistsawarenessofthesepreferences AT stalmeierpeepfm patientspreferencesforinformationaboutthebenefitsandrisksofsecondlinepalliativechemotherapyandtheironcologistsawarenessofthesepreferences |